Pancreatitis
174
28
29
76
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
12 trials with published results (7%)
Research Maturity
76 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
7.5%
13 terminated out of 174 trials
85.4%
-1.2% vs benchmark
16%
27 trials in Phase 3/4
16%
12 of 76 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 76 completed trials
Clinical Trials (174)
Scrambler Therapy in Chronic Pancreatitis
Supraglottic Oxygenation Via Oral Transtracheal Catheter for Reducing the Incidence of Hypoxemia During ERCP Under Sedation
Nucleosome Monitoring Relevance for Outcome Prediction in Critically Ill Patients
Rectal Indomethacin With or Without Papillary Ice Water Irrigation to Prevent Post-ERCP Pancreatitis
Intermittent Fasting for Pancreatitis
Influence of Gut Microbiome in Gallstone Disease
Iconographic Registry of Pancreatobiliary Endoscopy Procedures
Activation of Biobank Registry for Bilio-pancreatic Diseases
CBC-Derived Inflammatory Indices in Acute Pancreatitis
Phosphate in Acute Pancreatitis
Short-Stay Aggressive Hydration to Prevent Post-ERCP Pancreatitis
Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Building and Sustaining Exercise Habits for Adults With Type 1 Diabetes
Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain
PancRea: Risk Factors and Outcomes of Infected Pancreatic Necrosis
Indomethacin for Biliary ERCP Patients
Indomethacin vs Diclofenac for Preventing PEP
Prophylaxis Against Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis.
Evaluating the Efficacy of RELiZORB in Managing Exocrine Pancreatic Insufficiency in Tube-fed Pancreatitis Patients